Organization Profile

You just read:

Sophiris Bio Announces 12 Month Follow-Up Data from Phase 2b TRIUMPH Clinical Trial of PRX302 in Patients with Benign Prostatic Hyperplasia

News provided by

Sophiris Bio, Inc.

Oct 09, 2012, 07:00 ET